Biond Biologics and Guangzhou-Israel Biotechnology Fund (GIBF) Announce Strategic Investment and Joint Venture to Advance First-in-Class Oncology Programs in China
Two of Japan's most recognizable corporate names — a railway giant and a trading house — are combining their real estate arms in a deal that aims to reshape how land around train s......